Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
In person at the Big Data Institute, Seminar room 0
Alternatively, join on Zoom
aarhusuniversity.zoom.us/j/61873306999
Meeting ID: 618 7330 6999
Abstract
Type 2 diabetes is a clinically and biologically heterogeneous disease driven by diverse genetic, molecular, and environmental factors. Understanding this heterogeneity is essential to move beyond one-size-fits-all approaches and toward precision prevention and treatment strategies. In this talk, I will highlight recent work from my group and collaborators that dissects the genetic and molecular subtypes of T2D. I will discuss how these insights can help us refine disease classification, improve risk prediction, and inform individualized interventions. Finally, I will outline opportunities and challenges for translating this knowledge into precision health applications aimed at optimizing diabetes prevention and care.
Bio
I lead the Genomics and Precision Medicine research group at the Novo Nordisk Foundation Center for Basic Metabolic Research at the University of Copenhagen. The group focuses on understanding the molecular and clinical heterogeneity underlying diabetes and related metabolic diseases by integrating multi-omics profiling and deep phenotype data from wearable devices. These efforts have shed light on how molecular processes and behavioral factors influence diverse clinical trajectories, responses to therapeutic interventions, and varying propensities for developing cardiovascular complications, contributing to the field of precision medicine.
